Skip to search formSkip to main contentSkip to account menu

nitrosonifedipine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
New applications of approved clinically used drugs are being discovered. Drug repositioning is a proposed strategy for developing… 
2017
2017
Objective: Nitrosonifedipine (NO-NIF) is photolytic metabolite of nifedipine, an anti-hypertensive drug. We have revealed that NO… 
2016
2016
INTRODUCTION: Ischemic flap necrosis is often occurred by insufficient blood supply, which prolongs the treatment period and… 
2014
2014
Diabetic nephropathy (DN) is the major cause of end-stage renal failure. Oxidative stress is implicated in the pathogenesis of DN… 
2012
2012
Nifedipine is unstable under light and decomposes to a stable nitroso analog, nitrosonifedipine (NO-NIF). The ability of NO-NIF… 
2012
2012
Diabetic nephropathy (DN) is a major microvascular complication of diabetes involving oxidative stress and endothelial damage… 
2011
2011
Recently, increasing evidence suggests that the antihypertensive drug nifedipine acts as a protective agent for endothelial cells…